| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| Company: Abbott Laboratories |
| Recipient: An Immediate Family Member |
| Company: Pfizer |
| Recipient: An Immediate Family Member |
|
| Honoraria |
| Company: C-Stone |
| Recipient: You |
|
| Consulting or Advisory Role |
| Company: Blueprint Medicines |
| Recipient: You |
| Company: deciphera |
| Recipient: You |
| Company: Bayer |
| Recipient: You |
| Company: Lilly |
| Recipient: You |
| Company: UpToDate |
| Recipient: You |
| Company: Research to Practice |
| Recipient: You |
| Company: MORE Health |
| Recipient: You |
| Company: Daiichi |
| Recipient: You |
| Company: Kayothera |
| Recipient: You |
| Company: Immunicum |
| Recipient: You |
| Company: BioAtla |
| Recipient: You |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: BioAtla |
| Recipient: You |
| Company: Blueprint Medicines |
| Recipient: Your Institution |
| Company: Deciphera |
| Recipient: Your Institution |
| Company: Daiichi Sankyo RD Novare |
| Recipient: Your Institution |
| Company: Merck |
| Recipient: Your Institution |
| Company: Eisai |
| Recipient: Your Institution |
| Company: SpringWorks Therapeutics |
| Recipient: Your Institution |
| Company: TRACON Pharma |
| Recipient: Your Institution |
| Company: Theseus Pharmaceuticals |
| Recipient: Your Institution |
| Company: IDRX42 |
| Recipient: Your Institution |
| Company: NewBay Pharma |
| Recipient: Your Institution |
| Company: Acrivon |
| Recipient: Your Institution |
|
| Patents, Royalties, Other Intellectual Property |
| Please describe: UptoDate |
| Recipient: You |
|
| Expert Testimony |
| Company: Bayer |
| Recipient: You |
|
| Travel, Accommodations, Expenses |
| No Relationships to Disclose |
|
|
| Other Relationship |
| Company: Research to Practice |
| Recipient: You |
| Company: WCG |
| Recipient: You |
|
| (OPTIONAL) Uncompensated Relationships |
| not answered |
|
|
| (OPTIONAL) Open Payments Link |
| No Relationships to Disclose |
|
|